{"id":"W4225000929","doi":"10.14740/wjon1464","title":"Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy","year":2022,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Pembrolizumab; Immunotherapy; Hemophagocytic lymphohistiocytosis; Adverse effect; Internal medicine; Pediatrics; Immunology; Immune system; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002023677,0.0004850139,0.004544679,0.001931515,0.000192956,0.00002851818,0.0006453128,0.0002859265,0.01242295],"category_scores_gemma":[0.0003327383,0.0003713321,0.001718055,0.001162279,0.0001471127,0.00009934863,0.0003144874,0.002458822,0.000242213],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003182054,"about_ca_system_score_gemma":0.01074437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001397133,"about_ca_topic_score_gemma":0.000006016394,"domain_scores_codex":[0.9950149,0.0006346352,0.002710298,0.0003399509,0.0007425513,0.0005576634],"domain_scores_gemma":[0.9966777,0.0004743227,0.001666839,0.0005557064,0.0002416809,0.0003837787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005358361,0.000441756,0.000004001834,0.002951899,0.0007594815,0.001576583,0.000166655,0.000001412269,0.00006008843,0.00001364617,0.009593859,0.9838948],"study_design_scores_gemma":[0.003091709,0.003658482,0.00003883103,0.003078132,0.0005165123,0.004237171,0.0001126027,7.364947e-7,0.00003551393,0.00001374396,0.9849316,0.000284987],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001229653,0.9836299,0.000008103492,0.0008842951,0.001312417,0.000992853,0.00001203231,0.00002125099,0.01301621],"genre_scores_gemma":[0.00006429922,0.9900427,0.0003218747,0.0006861811,0.000809429,0.0001178551,0.00003150692,0.0001148373,0.007811347],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9836098,"threshold_uncertainty_score":0.9998739,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06882043454900784,"score_gpt":0.387105941612769,"score_spread":0.3182855070637611,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}